TIRYAQ E ARBA: A classical Unani Formulation to boost immunity
Unani System of medicine is one among the oldest systems of medicine that prevails till date with its efficient drugs derived from animal, plant and mineral resources. Over 2400 years ago the father of medicine, Hippocrates practiced it, however His medicine included a great deal of ancient Egyptian Medicine as well as important components of the ancient Mesopotamian traditions. This system of medicine has a detailed description of drugs that are utilized in many infectious diseases like influenza, pneumonia and other respiratory disorders. Unani scholars have prescribed several single drugs as well as compound formulations for the prevention and treatment of infectious diseases in general. Tiryaq e Arba is one such formulation, which is known to improve host immunity anytime or during the outbreak of epidemics, endemics and pandemics. Through this paper, an attempt has been made to present Unani concept of infectious and epidemic diseases and details of Tiryaq e Arba with a possible approach to manage Covid-19.
Keywords: Tiryaq e Arba, ingredients, epidemics, Unani Medicine.
2. Husain A, Sofi G, Dang R, Kumar N, Unani System of Medicine: Introduction and challenges, Medical Journal of Islamic World Academy of Sciences, 2010; 18(1):27-30.
3. Islam A, Origin and development of Unani Medicine: An analytical study, Intellectual Discourse, 2018; 26(1):23-49.
4. Sina I, Al-Qanoon fit Tibb, Aijaz publishing house: New Delhi, 2010; pp. 290-300.
5. Khan A, Ikseere azam (Kabiruddin Urdu translation), Idarah kitabus Shifa, New Delhi: 2011; pp. 916-20.
6. Razi Z, Kitab al-Hawi, Central Council for Research in Unani Medicine, New Delhi, 2008; pp. 309-318.
7. Samarqandi N, Al-asbab wa-alam'at (Kabiruddin Urdu translation), Aijaz Publishing house, New Delhi, 2007; pp. 499-506.
8. Ober WB, Aloush N, The plague at Granada, 1348-1349: Ibn Al-Khatib and ideas of contagion, Bulletin of the New York Academy of Medicine, 1982; 58(4):418–424.
9. Samarqandi N, Sharah Asbab, Aijaz Publishing House, New Delhi, 2010; pp.
10. Arzani A, Qarabadeen Qadri, Aijaz publishing house, New Delhi, 1998; pp. 511.
11. Anonymous, National Formulary of Unani Medicine, Ministry of Health and Family Welfare, Dept. of AYUSH, New Delhi, part (1):154.
12. Arzani A, Meezan ul Tib (Urdu), 1st Edition: pp-178-81,756.
13. Kabeeruddin HM, Al Qarabadeen, Central Council for Research in Unani Medicine, New Delhi, 2006; pp-1212.
14. Kabeeruddin HM, Al Qarabadeen-Volume II, Malik son’s publishers, Faisalabad, YNM; pp-413.
15. Kabeeruddin HM, Sharah Asbab-Volume III, Shaukat Book Depot, Gujrat, YNM; pp-180-186.
16. Jurjani A, Zakhira Khwarzam Shahi (Hadi Husain Khan Urdu Translation), Munshi Nawal Kishore, Lucknow, 1878; 3(10):1796.
17. Anonymous, Essential Drugs List-Unani Medicine, Ministry of AYUSH, New Delhi, 2013; pp. 2-4.
18. Anonymous, Physicochemical standards of Unani formulations, Central Council for Research in Unani Medicine, M/o Health and Family Welfare, Government of India, New Delhi, 1986; Part (1):145-146.
19. Mathew A, Taranalli AD, Torgal SS, Evaluation of Anti-inflammatory and Wound Healing Activity of Gentiana lutea L. Rhizome Extracts in Animals, Pharmaceutical Biology, 2008; 42(1):8-12.
20. Nurul AMA, Segovia F, Xavier MF, Gil E, Almajano MP, Screening of Antioxidant Activity of Gentian Lutea Root and Its Application in Oil-in Water Emulsions, Antioxidants (Basel), 2014; 3(2):455-71.
21. Nastasijevid B, Lazarevid T, Dimitrijevid S, Pašti I, Vujačid A, Joksid G, Inhibition of myeloperoxidase and antioxidative activity of Gentiana lutea L. extracts, Journal of Pharmaceutical and Biomedical Analysis, 2012; 66(7):191-6.
22. Kusar A, Zupancic A, Sentjurc M, Baricevic D, Free radical scavenging activities of yellow gentian (Gentiana lutea.L.) measured by electron spin resonance, Human and Experimental Toxicology, 2006; 25(10):599-604.
23. Conforti F, Statti G, Uznov D, Manichini F, Comparative chemical composition and antioxidant activities of wild and cultivated Laurus nobilis L. leaves and Foeniculum vulgare subsp. piperitum (Ucria) Coutinho seeds, Biological and Pharmaceutical Bulletin, 2006; 29(10):2056–2064.
24. Kang HW, Yu KW, Jun WJ, Chang IS, Han SB, Kim HY, Cho HY, Isolation and characterization of alkyl peroxy radical scavenging compound from leaves of Laurus nobilis, Biological and Pharmaceutical Bulletin, 2002; 25:102–108.
25. Dall’Acqua S, Phytochemical Composition and Antioxidant Activity of Laurus nobilis L. Leaf Infusion, Journal of Medicinal Food, 2009; 12(4):869–876.
26. Adriana C, Bay laurel (Laurus nobilis) as potential antiviral treatment in naturally BQCV infected honeybees; Virus Research, 2016; 222:29-33.
27. Kesiya K, Vinoth A, Studies on Antioxidant and Antiviral Potential of Ethanolic extract of Laurus Nobilis against Adenovirus Type VIII: in-vitro, in-vivo and in-silico Approach. International Journal of Pharma and Bio Sciences, 2018; 9(1):198-203.
28. Yerou KO, Laurus nobilis from Algeria and immune response, Banat's Journal of Biotechnology, 2017; 8(15):119-22.
29. Merouani N, Belhattab R, Sahli F, Evaluation of the biological activity of Aristolochia longa L. Extracts, International Journal of Pharmaceutical Sciences and Research, 2017; 8(5):1978-92.
30. Nasreddine EO, Evaluation of in Vitro Antioxidant and Antidiabetic Activities of Aristolochia longa Extracts, Evidence-Based Complementary and Alternative Medicine 2019; https://doi.org/10.1155/2019/7384735.
31. Benzakour G, Immunostimulatory potential of Aristolochia longa L. induced toxicity on liver, intestine and kidney in mice, Journal of Toxicology and Environmental Health Sciences, 2011; 3(8):214-222.
32. Othman RS, Rafaa RH, Nazar AN, Studying of Phytochemical, Nutritive values and Antioxidant ability of Commiphora myrrha, Al-Mustansiriyh Journal of Pharmaceutical Sciences, 2017; 17(1):21-33.
33. Amal AM, Chemical composition of essential oil and in vitro antioxidant and antimicrobial activities of crude extracts of Commiphora myrrha resin, Industrial Crops and Products, 2014; 57:10-16.
34. Mahboubi M, Kashani MT, The anti-dermatophyte activity of Commiphora molmol. Pharmaceutical Biology, 2016; 54(4):720-25.
35. Hanus LO, Rezunka T, Dembitsky VM, Moussaieff A, Myrrh-Commiphora chemistry, Biomed Papers, 2005; 149(1):3-28.
36. Ahmed KM, Suleiman EA, Ahmed AM, In vitro Antifungal activity of Commiphora myrrha extract against Aspergillus species, Imperial Journal of Interdisciplinary Research; 2016; 2(12):1071-77.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).